You'd think that with 18 years' experience in the field, the doc would have worked out that RGT i a short-term proposition at best.
Maybe there is a set up for SK-Pharma group to take over RGT in the near future - I notice the doc has not relinquished his "day job" at SK-Pharma group.
Ann: Argent BioPharma Appoints Dr Shlomo Sadoun to Advisory Board, page-2
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.61M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.5¢ | 24.0¢ | $136.4K | 546.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17159 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 106 | 2 |
View Market Depth
| Last trade - 14.49pm 20/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |